3EVvAx3l7 at orgio.net 3EVvAx3l7 at orgio.net
Mon Nov 20 20:10:26 EST 2000

LM Online Investments Recommendation

Shares Outstanding: 30,000,000
Float: 7,000,000
52 Week Trading Range: $.20 - $3.625
Current Price $3.00
Target Price: $9.00
Rating: Strong Buy


About the Company

FRESNO, Calif--In an effort to prepare for expected growth in corporate development, employees, and revenue, WellnessAmerica  
( OTC BB: WAME ) announced that it has closed an initial $8 million round of funding with a pledge of an additional $60 million expected to close within the next two months. The proceeds will aid
WellnessAmerica, Inc. in its acquisition and corporate development campaign that is anticipated to drive the Company to become a leader in the Alternative Health E-Commerce arena. The Company has designed a program that allows subscribers to have access to the world's largest electronic encyclopedia of alternative medicine gathered under one domain on the Internet.

Reasons to Own the Stock

WellnessAmerica is committed to it's B2B licenses allowing it's partners to build relationships with consumers and health care providers generating revenues thru several methods including licensing fee's from physicians, ad revenues, subscriptions, content value and portal retail sales of vitamins, herbs, skin care products, video, magazines, newsletters, page review fee's paid by search engines, licensee fee's from content syndicated, as well as product portals linked back to WellnessAmerica home products. 
Final Note

Serious investors due their own due diligence about this or any other investment opportunity. The alternative medicine market of over 20 million consumers has spent almost $6 billion on vitamin and weight loss products in the last 10 months alone and is definitely an industry to consider investing in.



Safe Harbor Statement

Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Except for historical information contained herein, the matters discussed are forward-looking statements that involve risks and uncertainties. When used herein, words such as "anticipate", "believe", "estimate", "expect" and "intend" and similar expressions, as they relate to the Company or its management,  identify forward-looking statements.
 Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following the effect of business and economic conditions; the impact of competitive products and pricing; capacity and supply constraints or difficulties; product development, commercialization or technological difficulties; the regulatory and trade environment; and the risk factors reported from time to time in the Company's  SEC reports. This material is for informational purposes only and should 
not be construed as an offer or solicitation of an offer to buy or sell 
securities. The Company undertakes no obligation to update any  forward-looking statements as a result of future events or developments. LM Online Investments received NO compensation.


More information about the Fluorpro mailing list

Send comments to us at biosci-help [At] net.bio.net